Evidence map›Paper›PMID 42029629›Full record

SynthesisMedical sciences (Basel, Switzerland)2026

Breast Cancer Risk in over 1.3 Million Women on Antipsychotic Therapy: Life-Saving Drugs or Hidden Trigger for Breast Cancer?

Enrico Altiero Giusto, Vittorio Oteri, Giorgio Guido, Delia Anamaria Bogdan, Jacopo Giuliani, Carlotta Giorgi, Paolo Pinton, Francesco Fiorica

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Enrico Altiero GiustoDepartment of Medical Sciences, Section of Experimental Medicine and Laboratory of Technologies for Advanced Therapy (LTTA), University of Ferrara, 44121 Ferrara, Italy.ORCID 0009-0001-8430-337X
Vittorio OteriDepartment of Clinical and Experimental Medicine, Endocrinology Section, Garibaldi-Nesima Hospital, University of Catania, Via Palermo, 636, 95122 Catania, Italy.ORCID 0000-0001-5210-8601
Giorgio GuidoDepartment of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia 89, 95123 Catania, Italy.
Delia Anamaria BogdanDepartment of Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.ORCID 0009-0006-3885-0395
Jacopo GiulianiDepartment of Clinical Oncology, Section of Radiation Oncology and Nuclear Medicine, AULSS 9 Scaligera, 37122 Verona, Italy.ORCID 0000-0003-4096-2514
Carlotta GiorgiDepartment of Medical Sciences, Section of Experimental Medicine and Laboratory of Technologies for Advanced Therapy (LTTA), University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-2494-7405
Paolo PintonDepartment of Medical Sciences, Section of Experimental Medicine and Laboratory of Technologies for Advanced Therapy (LTTA), University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0001-7108-6508
Francesco FioricaDepartment of Clinical Oncology, Section of Radiation Oncology and Nuclear Medicine, AULSS 9 Scaligera, 37122 Verona, Italy.ORCID 0000-0002-9404-3655

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antipsychotic AgentsBreast NeoplasmsFemaleHumansOdds RatioRisk FactorsAntipsychotic Agentsantipsychoticbreast cancerdrug therapyneuroleptics

Identifiers

PMID42029629
PMCPMC13204435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.